![](/img/cover-not-exists.png)
Efficacy of BGJ398, a fibroblast growth factor receptor 1-3 inhibitor, in patients with previously treated advanced urothelial carcinoma with FGFR3 alterations
Pal, Sumanta K, Rosenberg, Jonathan E, Hoffman-Censits, Jean H, Berger, Raanan, Quinn, David I, Galsky, Matthew D, Wolf, Juergen, Dittrich, Christian, Keam, Bhumsuk, Delord, Jean-Pierre, Schellens, JaLanguage:
english
Journal:
Cancer Discovery
DOI:
10.1158/2159-8290.CD-18-0229
Date:
May, 2018
File:
PDF, 901 KB
english, 2018